ARRDC3 and cancer: It is worth mentioning that enhancing the expression of miR-200b is beneficial in sensitizing cancer cells into chemotherapy, so that arrestin domain containing 3 (ARRDC3) elevates the efficacy of chemotherapy in TNBC cells via miR-200b up-regulation [229].